Many people think of leukemia as a childhood cancer—and while it is the most common type in children under 15, it actually occurs most often in adults older than 55, per the National Cancer Institute.
Many people think of leukemia as a childhood cancer—and while it is the most common type in children under 15, it actually occurs most often in adults older than 55, per the National Cancer Institute.
Leukemia exemplifies the transformation of modern medicine. Once almost always fatal and poorly understood, it can now in many cases be precisely classified and treated. The path to that point was ...
After repeated unsuccessful cancer treatments, even the strongest patients can lose hope. But former University of Virginia School of Medicine assistant professors Tomasz Cierpicki and Jolanta ...
Imagine a tiny superhero inside every cell of your body whose job is to stop damaged cells before they turn dangerous. That superhero is a gene called TP53, and for decades scientists have known it as ...
In one seamless experience, students can access visual learning, verified and cited responses and personalized support, all based on trusted United States Medical Licensing Examination (USMLE) aligned ...
ST. LOUIS — It's a powerful story of hope and medical innovation. A ground-breaking clinical trial, based in St. Louis, is showing promise in stopping Leukemia before it starts. Patient Joe Ragey said ...
New York Post may receive revenue from affiliate and advertising partnerships for sharing this content and/or when you make a purchase. We drink water every day. Several times a day, ideally. But ...
A little over a month after revealing to the world that she'd been diagnosed with cancer, Tatiana Schlossberg has died at age 35. "Our beautiful Tatiana passed away this morning," her family wrote in ...
Decades ago, patients who were diagnosed with acute myeloid leukemia, a rare cancer of the bone marrow and blood, were told there was nothing doctors could do for them. In part due to pioneering ...
EXCLUSIVE: Ra Kumar, who has worked at UTA for nearly 15 years, is the latest television agent to move into management. Kumar is launching Osmosis Management as a division of Osmosis Global, the ...
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results